Policy Analysis

Our policy work examines how biohybrid robotics can be governed before its applications become widespread. Working with Public Policy|Southampton, we combined horizon scanning, policy synthesis, and engagement with stakeholders from government, policy organisations, and academia.

Opportunities and consequences

Biohybrid robotics could lead to new applications in healthcare, environmental monitoring, search and rescue, and advanced manufacturing. It also raises questions that extend beyond conventional robotics: the use and disposal of living materials, dual-use and military applications, environmental release, sentience and autonomy, access to healthcare technologies, data, and public trust.

Our work considers these opportunities and consequences together. The aim is to understand where governance may be needed early, without closing down beneficial research and innovation.

Defining biohybrid robotics

There is currently no consistent definition of what constitutes a biohybrid robot. This makes it difficult to decide which technologies fall within the field and which regulatory pathways apply.

We propose a practical definition based on three criteria: a biohybrid robot must contain a biological component; this must be integrated with an artificial or engineered component; and the biological component must contribute to the system’s function, behaviour, or responsiveness. This distinguishes biohybrid robotics from adjacent fields such as biomimetics, tissue engineering, and neurotechnology.

The regulatory landscape

Biohybrid robotics is not simply unregulated. Relevant frameworks already govern human and animal tissues, medical devices, AI, data, machinery, and environmental safety. However, these frameworks were developed separately, while a single biohybrid robot may combine several of these elements.

The central problem is therefore one of regulatory coordination. Our report identifies classification, precedence, and lifecycle frictions: uncertainty over what a system is, which framework should lead, and how its regulatory identity may change as it moves from research to real-world use, or as its biological components grow, adapt, or decay.

Public trust and involvement

Our policy workshop showed that public perception should be treated as part of governance, not simply as a communications problem. Participants discussed the risk of a “yuck factor”, “Frankenstein” framings, and a public backlash similar to that experienced by other emerging biotechnologies.

They also identified areas in which public discussion may be needed, including the sourcing of animal tissues, possible sentience in neural organoids, and the use of neural data. Public involvement should begin before applications reach commercial maturity and should help shape the boundaries of acceptable development.

Anticipating what comes next

Our findings support early, coordinated, and adaptive governance. This does not necessarily require an entirely new regulatory system. It requires clearer definitions, better coordination between existing regulatory bodies, continued monitoring as applications develop, and public involvement in decisions about how the technology should be used.

The UK has an opportunity to shape these approaches before biohybrid technologies become widespread, commercialised, or politically contentious.

Policy report

Our policy report, Biohybrid Robotics: Emergence, Regulation and Consequence, brings this work together. It defines the field, examines the growth and geographical distribution of research, forecasts possible applications and consequences, maps the UK regulatory landscape, analyses potential points of regulatory friction, and presents findings from our policy engagement workshop.